Climate change and global warming have imposed new logistical challenges on the so-called Cold Chain. According to a report from Grand View Research, the market for refrigerated or frozen products is expected to reach $892.27 billion by 2030, growing at an annual rate of 19.2% from 2025. At the same time, extreme temperature fluctuations can compromise the integrity of sensitive items, such as food, vaccines, and medical supplies.
This context has demanded new technological solutions, such as temperature monitoring sensors along the logistics chain, to ensure quality control and prevent losses.
Specializing in logistics risk management, AHM Solution has part of its operations focused on the Cold Chain. ‘Among the solutions we offer are sensors that allow real-time monitoring of thermal conditions during transportation and storage, ensuring compliance with regulatory standards and product integrity,’ explains Afonso Moreira, the company’s CEO.
The systems provided by AHM Solution automatically alert shippers in case of deviations from the manufacturer’s recommended temperature, enabling quick actions to prevent losses.
‘Additionally, the loggers provide data on performance and temperature history throughout all stages of the logistics chain, aiding in strategic decision-making, which can even impact changes in the transportation network,’ adds Moreira.
One of the activities that requires strict, full-time temperature control is the logistics of organ or blood donations. In the case of organs, transportation must occur in a thermal box that maintains temperatures between 2 and 8°C. If it falls below or exceeds this range, the item must be discarded—something that is not uncommon. According to a study by the Ministry of Health and the Foundation for Education and Research in Health Sciences (Fepecs), out of 22,824 organs available between 2014 and 2021, about 60% were not used due to lack of adequate conditions.
As for blood bags, according to Anvisa (Brazil’s National Health Surveillance Agency), between 10% and 20% are discarded, mainly due to preservation failures and contamination.
Last year, a new temperature indicator device received certification from the FDA (Food and Drug Administration), the U.S. health surveillance agency. The HemoTemp II features an irreversible temperature sensor that alerts the user when the blood bag’s temperature exceeds 6°C. In Brazil, this solution is represented by AHM Solution.
‘Strict temperature control throughout the entire Cold Chain is not just a regulatory requirement but a vital necessity to preserve lives and prevent waste. In times of global warming, the use of advanced technologies becomes essential to ensure the efficiency and sustainability of these operations,’ says AHM Solution’s CEO.
